Formycon AG Company Profile, Contacts & Intelligence

Biotechnology ResearchPlanegg, Bayern, De194 employeesFounded 2012
3 contacts with email or phone data3 with email data2 with phone data
Employees
194
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 4 visible contacts
Departments
5
Mapped contact coverage

Formycon AG Overview

Who we are Formycon is a leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. The company focuses on treatments in ophthalmology, immunology and on other key chronic diseases, covering the entire value chain from technical development to the clinical phase III as well as the preparation of dossiers for marketing approval. With its biosimilars, Formycon is making a major contribution towards providing as many patients as possible with access to vital and affordable medicines. Formycon currently has four biosimilars in development. Based on its extensive experience in the development of biopharmaceutical drugs, the company is also working on the development of a COVID-19 drug FYB207 About Biosimilars: Since their introduction in the 1980s, biopharmaceuticals have revolutionized the treatment of serious diseases such as cancer, diabetes, rheumatoid arthritis, multiple sclerosis and eye diseases. In the coming years, many of these biotech drugs will lose their patent protection – and by 2020, medications with revenues of approximately USD 100 billion will be off patent. Biosimilars are follow-on versions of biopharmaceuticals, for which exclusivity has expired. They are approved via stringent regulatory pathways in highly regulated markets (such as EU, US, Japan, Canada, Australia) based on proven similarity of the biosimilar with the originator biopharmaceutical reference product. Global sales of biosimilars are estimated to exceed $15 billion by 2020. By 2030, analysts estimate that this figure could rise to over $60 billion. Contact: Formycon AG Fraunhoferstr. 15 82152 Martinsried/Planegg Germany phone +49 (0) 89 - 86 46 67 100 fax + 49 (0) 89 - 86 46 67 110 info@formycon.com

Headquarters
Planegg, Bayern, De
Industry
Biotechnology Research
Founded
2012
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

Formycon AG Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data and 2 with phone data in the visible sample.
5 departments represented
Visible contacts with email or phone data are mapped to these departments.
8 company-domain emails
Visible contacts using Formycon AG's company email domain.
General
3
Executive
2
Legal
2
Healthcare
1
IT
1

Formycon AG People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Formycon AG Workforce Composition

Seniority breakdown across 21 visible profiles.

Manager
8
Senior / Lead
5
Director
4
Executive
2
Individual contributor
1
Intern / trainee
1

Formycon AG Technology & Talent

Technology-related job titles represented in the visible people data.

Data / AI
2

Compare Similar Companies to Formycon AG

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Immatics Biotechnology Research 594 View company
MorphoSys Biotechnology Research 325 View company
Coriolis Pharma Pharmaceutical Manufacturing 173 View company
PROTEROS biostructures GmbH Biotechnology Research 148 View company
Medigene AG Biotechnology Research 88 View company
Immunic Therapeutics Biotechnology Research 87 View company
Tubulis GmbH Biotechnology Research 69 View company
iOmx Therapeutics AG Pharmaceutical Manufacturing 57 View company
Leukocare AG Biotechnology Research 47 View company
Eisbach Bio GmbH Biotechnology Research 11 View company